Clinical Trials Browser

Phase 1/2 × Terminated × Lapatinib × Clear all

NCT01118975 2019-11-13

GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers

Phase 1/2 Terminated

12 enrolled 6 charts

Breast Neoplasms, Neoplasm Metastasis

NCT01495884 2015-10-26

The Myocet/Lapatinib Study. ICORG 10-03, V5

Phase 1/2 Terminated

Her2 Positive Metastatic Breast Cancer

NCT01658358 2013-02-27

ErbB2 Positive Metastatic Breast Cancer

Phase 1/2 Terminated

Breast Neoplasms